Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Rossari Biotech surges in Q2 FY25: Profits jump 7.3% amid global expansion
Rossari Biotech Limited, a prominent manufacturer in the specialty chemicals sector, announced its financial performance for the second…
Alembic Pharmaceuticals secures final approval from FDA for hypertension drug
Alembic Pharmaceuticals Limited has successfully secured final approval from the US Food and Drug Administration (USFDA) for its…
InhaleRx secures A$38.5m deal to accelerate pain and mental health breakthroughs
Melbourne-based healthcare innovator InhaleRx Limited (ASX: IRX) has secured a substantial funding deal worth up to AUD 38.5…
Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce…
Minze Health secures $5.3m funding to expand urology digital health solutions in the US, Germany, and France
Minze Health, a leader in digital health solutions for urology, has secured a substantial $5.3 million in a…
Combatting malaria: AMIVAS launches first fully regulated injectable solution in Europe
AMIVAS Ireland Ltd has announced the launch of Artesunate AMIVAS, the first and only licensed treatment for severe…
OneSource secures $95m from leading investors; Strides Pharma shareholders witness surge in embedded value
OneSource Specialty Pharma Limited, previously known as Stelis Biopharma, has received equity commitments amounting to INR 8,010 million…
Akeso Biopharma raises $250m to accelerate international clinical trials
Akeso Biopharma has successfully raised approximately $250 million through a share placement, drawing significant recognition from international investment…
FDA approves Pfizer’s HYMPAVZI for breakthrough hemophilia treatment
In a major leap for hemophilia patients, Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug…
Study results spark 13% drop in Perspective Therapeutics shares – Radiation levels in focus
Shares of Perspective Therapeutics (NYSE AMERICAN: CATX) fell sharply, dropping over 13% to $11.49, after the latest data…